0000896262-21-000064.txt : 20210429
0000896262-21-000064.hdr.sgml : 20210429
20210429183105
ACCESSION NUMBER: 0000896262-21-000064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210427
FILED AS OF DATE: 20210429
DATE AS OF CHANGE: 20210429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kemmerly David L
CENTRAL INDEX KEY: 0001673554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 21872756
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_161973544203901.xml
FORM 4
X0306
4
2021-04-27
0
0000896262
AMEDISYS INC
AMED
0001673554
Kemmerly David L
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
See Remarks
Common Stock
2021-04-27
4
M
0
3125
27.35
A
23542
D
Common Stock
2021-04-27
4
S
0
4875
290.12
D
18667
D
Common Stock
506
I
Through 401(k) Plan
Stock Option (Right to Buy)
27.35
2021-04-27
4
M
0
3125
0
D
2025-05-01
Common Stock
3125.0
0
D
The total amount of shares beneficially owned includes 271 shares held in an employee stock purchase plan account.
These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.00 to $290.92, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The information in this report is based on a plan statement dated as of March 31, 2021.
On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 9,375 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019, and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transaction being reported herein, the reporting person has exercised all of the 2018 Tranche Options.
Chief Legal and Government Affairs Officer
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2021-04-29